Aurobindo Pharma Ltd - Company Profile
Powered by 
All the data and insights you need on Aurobindo Pharma Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Aurobindo Pharma Ltd Strategy Report
- Understand Aurobindo Pharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Aurobindo Pharma Catalyst Calendar
Proactively evaluate Aurobindo Pharma Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Aurobindo Pharma Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Oct 2020 | Phase I Trial Initiation | Acrotech Biopharma LLC; Huntsman Cancer Institute; Novartis AG; University of Utah | NOVN | belinostat; ribociclib succinate | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer); Metastatic Breast Cancer; Ovarian Cancer; Triple-Negative Breast Cancer (TNBC) | Clinical Trial Registry |
| 01 Aug 2020 | Phase I Trial Completion | Acrotech Biopharma LLC; AXIS Clinicals Limited.; Navitas Life Sciences Ltd | - | CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone]; pralatrexate | Oncology | Anaplastic Large Cell Lymphoma (ALCL); Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy; Peripheral T-Cell Lymphomas (PTCL) | Clinical Trial Registry |
| 15 Jun 2020 | Phase I Trial Initiation | CuraTeQ Biologics GmbH (Inactive); Parexel International Corp; Q-Pharm Pty Ltd | - | pegfilgrastim | Toxicology | Chemotherapy Induced Neutropenia | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer